SENORES PHARMACEUTICALS
|
SENORES PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| EQUITY AND LIABILITIES | ||||
| Share Capital | ₹46 Cr | ₹31 Cr | ₹9.82 Cr | ₹8.74 Cr |
| Equity - Authorised | ₹54 Cr | ₹54 Cr | ₹20 Cr | ₹20 Cr |
| Equity - Issued | ₹46 Cr | ₹31 Cr | ₹9.82 Cr | ₹8.74 Cr |
| Equity Paid Up | ₹46 Cr | ₹31 Cr | ₹9.82 Cr | ₹8.74 Cr |
| Equity Shares Forfeited | - | - | - | - |
| Adjustments to Equity | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - |
| Total Reserves | ₹740 Cr | ₹174 Cr | ₹36 Cr | ₹28 Cr |
| Securities Premium | ₹655 Cr | ₹134 Cr | ₹25 Cr | ₹24 Cr |
| Capital Reserves | ₹0.14 Cr | ₹0.14 Cr | ₹1.36 Cr | ₹2.54 Cr |
| Profit & Loss Account Balance | ₹90 Cr | ₹42 Cr | ₹10 Cr | ₹1.68 Cr |
| General Reserves | - | - | - | - |
| Other Reserves | ₹-4.98 Cr | ₹-2.19 Cr | ₹-0.97 Cr | ₹0.06 Cr |
| Reserve excluding Revaluation Reserve | ₹740 Cr | ₹174 Cr | ₹36 Cr | ₹28 Cr |
| Revaluation reserve | - | - | - | - |
| Shareholder's Funds | ₹786 Cr | ₹204 Cr | ₹45 Cr | ₹37 Cr |
| Minority Interest | ₹26 Cr | ₹27 Cr | - | - |
| Long-Term Borrowings | - | - | - | - |
| Secured Loans | ₹81 Cr | ₹28 Cr | - | ₹0.00 Cr |
| Non Convertible Debentures | - | - | - | - |
| Converible Debentures & Bonds | - | ₹65 Cr | ₹20 Cr | ₹0.00 Cr |
| Packing Credit - Bank | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - |
| Term Loans - Banks | ₹172 Cr | ₹43 Cr | - | - |
| Term Loans - Institutions | - | - | - | - |
| Other Secured | ₹-91 Cr | ₹-80 Cr | ₹-20 Cr | - |
| Unsecured Loans | ₹82 Cr | ₹106 Cr | ₹30 Cr | ₹12 Cr |
| Fixed Deposits - Public | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | ₹24 Cr | ₹10 Cr |
| Foreign Currency Convertible Notes | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - |
| Loans - Banks | - | - | - | - |
| Loans - Govt. | - | - | - | - |
| Loans - Others | ₹101 Cr | ₹103 Cr | ₹8.96 Cr | ₹2.09 Cr |
| Other Unsecured Loan | ₹-20 Cr | ₹3.00 Cr | ₹-2.87 Cr | - |
| Deferred Tax Assets / Liabilities | ₹-19 Cr | ₹-15 Cr | ₹2.10 Cr | ₹-0.45 Cr |
| Deferred Tax Assets | ₹38 Cr | ₹38 Cr | ₹0.17 Cr | ₹0.45 Cr |
| Deferred Tax Liability | ₹19 Cr | ₹23 Cr | ₹2.27 Cr | - |
| Other Long Term Liabilities | ₹8.20 Cr | ₹7.78 Cr | ₹1.58 Cr | ₹0.41 Cr |
| Long Term Trade Payables | - | - | - | - |
| Long Term Provisions | ₹3.26 Cr | ₹1.24 Cr | ₹0.26 Cr | ₹0.05 Cr |
| Total Non-Current Liabilities | ₹155 Cr | ₹128 Cr | ₹34 Cr | ₹12 Cr |
| Current Liabilities | - | - | - | - |
| Trade Payables | ₹67 Cr | ₹113 Cr | ₹14 Cr | ₹7.14 Cr |
| Sundry Creditors | ₹67 Cr | ₹113 Cr | ₹14 Cr | ₹7.14 Cr |
| Acceptances | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - |
| Other Current Liabilities | ₹127 Cr | ₹94 Cr | ₹28 Cr | ₹0.62 Cr |
| Bank Overdraft / Short term credit | - | - | - | - |
| Advances received from customers | ₹0.96 Cr | ₹0.93 Cr | - | - |
| Interest Accrued But Not Due | ₹0.05 Cr | ₹0.11 Cr | - | - |
| Share Application Money | - | - | - | - |
| Current maturity of Debentures & Bonds | - | ₹65 Cr | ₹20 Cr | - |
| Current maturity - Others | - | - | - | - |
| Other Liabilities | ₹126 Cr | ₹28 Cr | ₹8.47 Cr | ₹0.62 Cr |
| Short Term Borrowings | ₹31 Cr | ₹32 Cr | ₹8.16 Cr | ₹1.99 Cr |
| Secured ST Loans repayable on Demands | ₹14 Cr | ₹32 Cr | ₹8.16 Cr | ₹1.99 Cr |
| Working Capital Loans- Sec | ₹14 Cr | ₹32 Cr | ₹3.16 Cr | ₹1.99 Cr |
| Buyers Credits - Unsec | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - |
| Other Unsecured Loans | ₹4.11 Cr | ₹-32 Cr | ₹-3.16 Cr | ₹-1.99 Cr |
| Short Term Provisions | ₹16 Cr | ₹8.49 Cr | ₹1.67 Cr | ₹0.14 Cr |
| Proposed Equity Dividend | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - |
| Provision for Tax | ₹13 Cr | ₹7.11 Cr | ₹1.59 Cr | ₹0.13 Cr |
| Provision for post retirement benefits | - | - | - | - |
| Preference Dividend | - | - | - | - |
| Other Provisions | ₹2.06 Cr | ₹1.38 Cr | ₹0.08 Cr | ₹0.01 Cr |
| Total Current Liabilities | ₹241 Cr | ₹248 Cr | ₹52 Cr | ₹9.88 Cr |
| Total Liabilities | ₹1,208 Cr | ₹607 Cr | ₹131 Cr | ₹59 Cr |
| ASSETS | ||||
| Gross Block | ₹331 Cr | ₹249 Cr | ₹30 Cr | ₹8.17 Cr |
| Less: Accumulated Depreciation | ₹30 Cr | ₹13 Cr | ₹3.06 Cr | ₹1.28 Cr |
| Less: Impairment of Assets | - | - | - | - |
| Net Block | ₹301 Cr | ₹235 Cr | ₹27 Cr | ₹6.90 Cr |
| Lease Adjustment A/c | - | - | - | - |
| Capital Work in Progress | ₹44 Cr | ₹18 Cr | ₹8.06 Cr | ₹0.35 Cr |
| Non Current Investments | ₹0.01 Cr | ₹0.01 Cr | ₹16 Cr | ₹15 Cr |
| Long Term Investment | ₹0.01 Cr | ₹0.01 Cr | ₹16 Cr | ₹15 Cr |
| Quoted | - | - | - | - |
| Unquoted | ₹0.01 Cr | ₹0.01 Cr | ₹16 Cr | ₹15 Cr |
| Long Term Loans & Advances | ₹8.67 Cr | ₹4.02 Cr | ₹1.16 Cr | ₹1.14 Cr |
| Other Non Current Assets | ₹3.89 Cr | ₹19 Cr | ₹0.40 Cr | ₹0.14 Cr |
| Total Non-Current Assets | ₹486 Cr | ₹356 Cr | ₹80 Cr | ₹32 Cr |
| Current Assets Loans & Advances | - | - | - | - |
| Currents Investments | - | - | - | - |
| Quoted | - | - | - | - |
| Unquoted | - | - | - | - |
| Inventories | ₹57 Cr | ₹37 Cr | ₹3.12 Cr | ₹2.98 Cr |
| Raw Materials | ₹35 Cr | ₹19 Cr | ₹0.17 Cr | ₹0.43 Cr |
| Work-in Progress | ₹2.22 Cr | ₹5.20 Cr | - | - |
| Finished Goods | ₹2.42 Cr | ₹2.45 Cr | - | - |
| Packing Materials | ₹6.53 Cr | ₹4.71 Cr | ₹0.07 Cr | ₹0.16 Cr |
| Stores  and Spare | ₹4.57 Cr | ₹3.08 Cr | - | - |
| Other Inventory | ₹6.38 Cr | ₹2.61 Cr | ₹2.88 Cr | ₹2.40 Cr |
| Sundry Debtors | ₹124 Cr | ₹112 Cr | ₹22 Cr | ₹20 Cr |
| Debtors more than Six months | ₹44 Cr | ₹23 Cr | - | ₹1.69 Cr |
| Debtors Others | ₹80 Cr | ₹90 Cr | ₹22 Cr | ₹18 Cr |
| Cash and Bank | ₹386 Cr | ₹13 Cr | ₹0.10 Cr | ₹3.22 Cr |
| Cash in hand | ₹0.30 Cr | ₹0.13 Cr | ₹0.03 Cr | ₹0.09 Cr |
| Balances at Bank | ₹385 Cr | ₹13 Cr | ₹0.07 Cr | ₹3.13 Cr |
| Other cash and bank balances | - | - | - | - |
| Other Current Assets | ₹7.27 Cr | ₹3.03 Cr | ₹1.20 Cr | ₹0.01 Cr |
| Interest accrued on Investments | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - |
| Deposits with Government | - | - | - | - |
| Interest accrued and or due on loans | ₹0.06 Cr | - | - | - |
| Prepaid Expenses | ₹7.21 Cr | ₹3.03 Cr | ₹1.20 Cr | ₹0.01 Cr |
| Other current_assets | - | - | - | - |
| Short Term Loans and Advances | ₹149 Cr | ₹85 Cr | ₹25 Cr | ₹1.21 Cr |
| Advances recoverable in cash or in kind | ₹121 Cr | ₹71 Cr | ₹22 Cr | ₹0.18 Cr |
| Advance income tax and TDS | - | - | - | - |
| Amounts due from directors | - | - | - | - |
| Due From Subsidiaries | - | - | - | - |
| Inter corporate deposits | - | - | - | - |
| Corporate Deposits | - | - | - | - |
| Other Loans & Advances | ₹28 Cr | ₹15 Cr | ₹2.36 Cr | ₹1.03 Cr |
| Total Current Assets | ₹722 Cr | ₹251 Cr | ₹51 Cr | ₹27 Cr |
| Net Current Assets (Including Current Investments) | ₹482 Cr | ₹3.41 Cr | ₹-0.55 Cr | ₹17 Cr |
| Miscellaneous Expenses not written off | - | - | - | - |
| Total Assets | ₹1,208 Cr | ₹607 Cr | ₹131 Cr | ₹59 Cr |
| Contingent Liabilities | ₹21 Cr | ₹23 Cr | ₹8.35 Cr | - |
| Total Debt | ₹305 Cr | ₹248 Cr | ₹61 Cr | ₹14 Cr |
| Book Value | 170.72 | 66.95 | 46.36 | 41.86 |
| Adjusted Book Value | 170.72 | 66.95 | 46.36 | 41.86 |
Compare Balance Sheet of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,131.1 Cr | 3.3% | 19% | 151.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 3.3% |
19% |
151.5% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses